NCT04865783

Brief Summary

This trial aims to evaluate if cryospray can reduce pain during intravenous cannulation in elective surgery compared to a placebo spray.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 29, 2021

Completed
26 days until next milestone

Study Start

First participant enrolled

May 25, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 18, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 18, 2023

Completed
Last Updated

May 31, 2024

Status Verified

May 1, 2024

Enrollment Period

2.1 years

First QC Date

April 28, 2021

Last Update Submit

May 30, 2024

Conditions

Keywords

cryospray

Outcome Measures

Primary Outcomes (1)

  • Patients reported pain from the puncture site

    After vein puncture is completed patients is asked on a scale from 0-10 to indicate pain during vein canulation (zero no pain, 10 worst possible pain)

    immediately after completion of vein canulation

Secondary Outcomes (2)

  • Difficulty in placement of intravenous line

    immediately after completion of vein canulation

  • Number of successful placements of venous line at first attempt

    immediately after completion of vein canulation

Other Outcomes (1)

  • Discomfort from puncture site at discharge from recovery

    up to 24 hours after discharge from recovery room

Study Arms (2)

Cryospray

ACTIVE COMPARATOR

Cryospray will be sprayed from a distance of 20-30 cm to the back of one hand.

Procedure: Cryospray

Placebo

PLACEBO COMPARATOR

A saline solution will be sprayed from a distance of 20-30 cm to the back of the hand.

Procedure: Saline spray

Interventions

Saline sprayPROCEDURE

The saline spray will be applied twice for 1-2 seconds.

Placebo
CryosprayPROCEDURE

The cryospray will be applied twice for 1-2 seconds.

Cryospray

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older and able to give consent

You may not qualify if:

  • Unable to give consent
  • Infection
  • coloring or bruises at the puncture site (use of corticosteroid etc).
  • No vein signs visible after application of vein stasis.
  • Allergy to coolant spray.
  • Contraindication for vein stasis or vein cannulation (ex Raynauds disease etc).
  • Has participated earlier in the trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sygehus Soenderjylland

Aabenraa, 6200, Denmark

Location

Related Publications (4)

  • Mace SE. Prospective, randomized, double-blind controlled trial comparing vapocoolant spray vs placebo spray in adults undergoing venipuncture. Am J Emerg Med. 2016 May;34(5):798-804. doi: 10.1016/j.ajem.2016.01.002. Epub 2016 Jan 7.

    PMID: 26979261BACKGROUND
  • Griffith RJ, Jordan V, Herd D, Reed PW, Dalziel SR. Vapocoolants (cold spray) for pain treatment during intravenous cannulation. Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD009484. doi: 10.1002/14651858.CD009484.pub2.

    PMID: 27113639BACKGROUND
  • Zhu Y, Peng X, Wang S, Chen W, Liu C, Guo B, Zhao L, Gao Y, Wang K, Lou F. Vapocoolant spray versus placebo spray/no treatment for reducing pain from intravenous cannulation: A meta-analysis of randomized controlled trials. Am J Emerg Med. 2018 Nov;36(11):2085-2092. doi: 10.1016/j.ajem.2018.03.068. Epub 2018 Mar 27.

    PMID: 30253890BACKGROUND
  • Pedersen JB, Martensen A, Funder P, Bakke SA, Bhavsar RP, Strom T. Cryospray reduces pain during venous cannulation in elective surgery patients: a randomized placebo-controlled study. BMC Anesthesiol. 2024 Dec 19;24(1):466. doi: 10.1186/s12871-024-02858-2.

Study Officials

  • Thomas Strøm

    University Hospital of Southern Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Before elective surgery, all patients will have an intravenous line placed before induction of anaesthesia. Patients will be blinded to whether cryospray or placebo is used. Two anaesthesia trained persons (nurse/doctors) will perform the procedure. One person will randomize and apply the randomized spray and the other person will be blinded to the randomized treatment. The anesthesiologist performing the puncture but blinded for randomization will fill out a questionnaire
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2021

First Posted

April 29, 2021

Study Start

May 25, 2021

Primary Completion

July 18, 2023

Study Completion

July 18, 2023

Last Updated

May 31, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations